NM_003579.4:c.2190C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003579.4(RAD54L):​c.2190C>T​(p.Ala730Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.13 in 1,613,356 control chromosomes in the GnomAD database, including 17,922 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1240 hom., cov: 32)
Exomes 𝑓: 0.13 ( 16682 hom. )

Consequence

RAD54L
NM_003579.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.21

Publications

35 publications found
Variant links:
Genes affected
RAD54L (HGNC:9826): (RAD54 like) The protein encoded by this gene belongs to the DEAD-like helicase superfamily, and shares similarity with Saccharomyces cerevisiae Rad54, a protein known to be involved in the homologous recombination and repair of DNA. This protein has been shown to play a role in homologous recombination related repair of DNA double-strand breaks. The binding of this protein to double-strand DNA induces a DNA topological change, which is thought to facilitate homologous DNA paring, and stimulate DNA recombination. Alternative splicing results in multiple transcript variants encoding the same protein.[provided by RefSeq, Dec 2008]
LRRC41 (HGNC:16917): (leucine rich repeat containing 41) Predicted to enable identical protein binding activity. Predicted to be involved in protein ubiquitination. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 1-46278228-C-T is Benign according to our data. Variant chr1-46278228-C-T is described in ClinVar as Benign. ClinVar VariationId is 1678943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.21 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAD54LNM_003579.4 linkc.2190C>T p.Ala730Ala synonymous_variant Exon 18 of 18 ENST00000371975.9 NP_003570.2
LRRC41NM_006369.5 linkc.*637G>A 3_prime_UTR_variant Exon 10 of 10 ENST00000617190.5 NP_006360.3
RAD54LNM_001142548.2 linkc.2190C>T p.Ala730Ala synonymous_variant Exon 19 of 19 NP_001136020.1
RAD54LNM_001370766.1 linkc.1650C>T p.Ala550Ala synonymous_variant Exon 18 of 18 NP_001357695.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAD54LENST00000371975.9 linkc.2190C>T p.Ala730Ala synonymous_variant Exon 18 of 18 1 NM_003579.4 ENSP00000361043.4
LRRC41ENST00000617190.5 linkc.*637G>A 3_prime_UTR_variant Exon 10 of 10 1 NM_006369.5 ENSP00000477792.1

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16389
AN:
151962
Hom.:
1239
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0438
Gnomad AMI
AF:
0.100
Gnomad AMR
AF:
0.0995
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.306
Gnomad SAS
AF:
0.372
Gnomad FIN
AF:
0.0848
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.116
Gnomad OTH
AF:
0.139
GnomAD2 exomes
AF:
0.152
AC:
37888
AN:
250040
AF XY:
0.166
show subpopulations
Gnomad AFR exome
AF:
0.0419
Gnomad AMR exome
AF:
0.0962
Gnomad ASJ exome
AF:
0.125
Gnomad EAS exome
AF:
0.299
Gnomad FIN exome
AF:
0.0902
Gnomad NFE exome
AF:
0.116
Gnomad OTH exome
AF:
0.148
GnomAD4 exome
AF:
0.132
AC:
193512
AN:
1461276
Hom.:
16682
Cov.:
32
AF XY:
0.140
AC XY:
101963
AN XY:
726888
show subpopulations
African (AFR)
AF:
0.0427
AC:
1428
AN:
33476
American (AMR)
AF:
0.0950
AC:
4242
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.125
AC:
3277
AN:
26124
East Asian (EAS)
AF:
0.324
AC:
12850
AN:
39672
South Asian (SAS)
AF:
0.365
AC:
31407
AN:
86120
European-Finnish (FIN)
AF:
0.0938
AC:
5007
AN:
53370
Middle Eastern (MID)
AF:
0.218
AC:
1254
AN:
5754
European-Non Finnish (NFE)
AF:
0.113
AC:
125804
AN:
1111724
Other (OTH)
AF:
0.137
AC:
8243
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
10902
21804
32705
43607
54509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4780
9560
14340
19120
23900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.108
AC:
16390
AN:
152080
Hom.:
1240
Cov.:
32
AF XY:
0.113
AC XY:
8387
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0436
AC:
1811
AN:
41528
American (AMR)
AF:
0.0994
AC:
1520
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
453
AN:
3470
East Asian (EAS)
AF:
0.307
AC:
1579
AN:
5148
South Asian (SAS)
AF:
0.372
AC:
1794
AN:
4828
European-Finnish (FIN)
AF:
0.0848
AC:
899
AN:
10598
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.116
AC:
7892
AN:
67910
Other (OTH)
AF:
0.142
AC:
299
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
725
1450
2174
2899
3624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.118
Hom.:
3462
Bravo
AF:
0.101
Asia WGS
AF:
0.298
AC:
1034
AN:
3478
EpiCase
AF:
0.125
EpiControl
AF:
0.125

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 22, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

RAD54L-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
10
DANN
Benign
0.86
PhyloP100
1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1048771; hg19: chr1-46743900; COSMIC: COSV58441949; COSMIC: COSV58441949; API